[Confirmation of a liver-protecting action of L-ornithine-L-aspartate using the experimental model of hypokalaemic liver damage].
D000410:Alanine Transaminase / Q000097:blood; D000818:Animals; D001219:Aspartate Aminotransferases / Q000097:blood; D001224:Aspartic Acid / Q000008:administration & dosage*; D007008:Hypokalemia / Q000150:complications / Q000201:enzymology / Q000378:metabolism*; D008099:Liver / Q000378:metabolism*; D008107:Liver Diseases / Q000201:enzymology / Q000209:etiology / Q000517:prevention & control*; D008297:Male; D009952:Ornithine / Q000008:administration & dosage*; D051381:Rats
D001224:Aspartic Acid; D009952:Ornithine; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase
Experimenteller Nachweis einer Leberschutzwirkung des L-Ornithin-L-Aspartats am Modell der Schädigung burch Hypokaliämie.